Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]

Background Opioids are frequently prescribed for short-term acute pain following surgery. Used appropriately, opioids deliver extremely favourable pain relief. Used longer than 90-days, however, can result in health complications, including unintentional overdose and addiction. Globally, >40 mill...

Full description

Saved in:
Bibliographic Details
Main Authors: Ellie Santer, Julie H Hedayioglu, Vanessa J Short, Sabina Hulbert, Emma L Veale, Melanie Rees-Roberts, Johanna Theron
Format: Article
Language:English
Published: F1000 Research Ltd 2025-01-01
Series:NIHR Open Research
Subjects:
Online Access:https://openresearch.nihr.ac.uk/articles/4-48/v2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590333810049024
author Ellie Santer
Julie H Hedayioglu
Vanessa J Short
Sabina Hulbert
Emma L Veale
Melanie Rees-Roberts
Johanna Theron
author_facet Ellie Santer
Julie H Hedayioglu
Vanessa J Short
Sabina Hulbert
Emma L Veale
Melanie Rees-Roberts
Johanna Theron
author_sort Ellie Santer
collection DOAJ
description Background Opioids are frequently prescribed for short-term acute pain following surgery. Used appropriately, opioids deliver extremely favourable pain relief. Used longer than 90-days, however, can result in health complications, including unintentional overdose and addiction. Globally, >40 million people are dependent on opioids and annually >100,000 die from opioid misuse. With >4.7 million surgical procedures occurring annually in the United Kingdom it is imperative that opioid-use is managed upon discharge. A declining General Practitioner (GP) workforce and increased patient numbers, however, means gaps in healthcare during transfer of care. Here we report a mixed-methods protocol to understand the feasibility, and acceptability of a clinical pharmacist (CP)-led early opioid deprescribing intervention for discharged surgical patients. Methods DESCALE is a multicentre, non-randomised, pragmatic feasibility study. Participants aged ≥18 years who have undergone a surgical procedure at a single NHS trust in Southeast England and discharged with opioids and without a history of long-term opioid use, cancer diagnosis or study contraindications will be offered a Medicines Use Review (MUR) within 7-10 days of discharge. The MUR will be delivered by CPs at participating GP practices. Feasibility outcomes will focus on recruitment, fidelity of CPs to deliver the MUR, and barriers within primary care that affect delivery of the intervention, with a maximum sample size of 100. Clinical outcomes will focus on the number of participants that reduce or stop opioid use within 91 days. Prescribing, medical, surgical, and demographic data for individual participants will be collected and analysed to inform future trial design. Qualitative interviews with participants and associated healthcare professionals will explore acceptability and implementation of the intervention. Conclusion Data collected with respect to opioid use post-surgery, feasibility and acceptability of the intervention, patient experience and outcome data will inform the design of future research and larger clinical trials.
format Article
id doaj-art-6f75a9f6e22b402facec0046ef9af42b
institution Kabale University
issn 2633-4402
language English
publishDate 2025-01-01
publisher F1000 Research Ltd
record_format Article
series NIHR Open Research
spelling doaj-art-6f75a9f6e22b402facec0046ef9af42b2025-01-24T01:00:00ZengF1000 Research LtdNIHR Open Research2633-44022025-01-01415070Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]Ellie Santer0Julie H Hedayioglu1https://orcid.org/0000-0002-9805-7421Vanessa J Short2https://orcid.org/0000-0001-6231-0707Sabina Hulbert3Emma L Veale4https://orcid.org/0000-0002-6778-9929Melanie Rees-Roberts5Johanna Theron6https://orcid.org/0009-0005-5417-545XCentre for Health Services Studies, University of Kent, Canterbury, England, CT2 7NF, UKResearch & Development, Kent Community Health NHS Foundation Trust, Ashford, England, TN25 4AZ, UKCentre for Health Services Studies, University of Kent, Canterbury, England, CT2 7NF, UKCentre for Health Services Studies, University of Kent, Canterbury, England, CT2 7NF, UKMedway School of Pharmacy, University of Kent and University of Greenwich, Chatham Maritime, ME4 4TB, UKCentre for Health Services Studies, University of Kent, Canterbury, England, CT2 7NF, UKCommunity Chronic Pain Team, Kent Community Health NHS Foundation Trust, Margate, CT9 1LB, UKBackground Opioids are frequently prescribed for short-term acute pain following surgery. Used appropriately, opioids deliver extremely favourable pain relief. Used longer than 90-days, however, can result in health complications, including unintentional overdose and addiction. Globally, >40 million people are dependent on opioids and annually >100,000 die from opioid misuse. With >4.7 million surgical procedures occurring annually in the United Kingdom it is imperative that opioid-use is managed upon discharge. A declining General Practitioner (GP) workforce and increased patient numbers, however, means gaps in healthcare during transfer of care. Here we report a mixed-methods protocol to understand the feasibility, and acceptability of a clinical pharmacist (CP)-led early opioid deprescribing intervention for discharged surgical patients. Methods DESCALE is a multicentre, non-randomised, pragmatic feasibility study. Participants aged ≥18 years who have undergone a surgical procedure at a single NHS trust in Southeast England and discharged with opioids and without a history of long-term opioid use, cancer diagnosis or study contraindications will be offered a Medicines Use Review (MUR) within 7-10 days of discharge. The MUR will be delivered by CPs at participating GP practices. Feasibility outcomes will focus on recruitment, fidelity of CPs to deliver the MUR, and barriers within primary care that affect delivery of the intervention, with a maximum sample size of 100. Clinical outcomes will focus on the number of participants that reduce or stop opioid use within 91 days. Prescribing, medical, surgical, and demographic data for individual participants will be collected and analysed to inform future trial design. Qualitative interviews with participants and associated healthcare professionals will explore acceptability and implementation of the intervention. Conclusion Data collected with respect to opioid use post-surgery, feasibility and acceptability of the intervention, patient experience and outcome data will inform the design of future research and larger clinical trials.https://openresearch.nihr.ac.uk/articles/4-48/v2Opioids deprescribing surgery dependence clinical pharmacists Medicines Use Revieweng
spellingShingle Ellie Santer
Julie H Hedayioglu
Vanessa J Short
Sabina Hulbert
Emma L Veale
Melanie Rees-Roberts
Johanna Theron
Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
NIHR Open Research
Opioids
deprescribing
surgery
dependence
clinical pharmacists
Medicines Use Review
eng
title Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
title_full Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
title_fullStr Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
title_full_unstemmed Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
title_short Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) – A multi-centre, non-randomised, feasibility study protocol [version 2; peer review: 1 approved, 2 approved with reservations]
title_sort pharmacist led de escalation of opioids post surgical discharge descale a multi centre non randomised feasibility study protocol version 2 peer review 1 approved 2 approved with reservations
topic Opioids
deprescribing
surgery
dependence
clinical pharmacists
Medicines Use Review
eng
url https://openresearch.nihr.ac.uk/articles/4-48/v2
work_keys_str_mv AT elliesanter pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT juliehhedayioglu pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT vanessajshort pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT sabinahulbert pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT emmalveale pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT melaniereesroberts pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations
AT johannatheron pharmacistleddeescalationofopioidspostsurgicaldischargedescaleamulticentrenonrandomisedfeasibilitystudyprotocolversion2peerreview1approved2approvedwithreservations